EUTM file information

018451280

XGene Pharmaceutical


April 12, 2021

Trademark Summary

The trademark application XGene Pharmaceutical was filed by XGENE PHARMACEUTICAL INC., a corporation established under the laws of the Cayman Islands (the "Applicant"). The application was published for oppositions on June 14, 2021, and it was registered by office on September 21, 2021 without any oppositions.

The application was filed in English (German was selected as the second language).


Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Vaccines
    2. Medicines for human purposes
    3. Pharmaceutical preparations for the treatment of viral diseases
    4. Pharmaceutical products for the treatment of cancer
    5. Biological preparations for the treatment of cancer
    6. Pain relief medication
    7. Biological preparations for medical purposes
    8. Antibiotics
    9. Protein supplements
    10. Chemico-pharmaceutical preparations
    11. Pharmaceutical preparations for the treatment of immune system related diseases and disorders
    12. Pharmaceutical preparations for treating skin disorders
    13. Dermatological pharmaceutical products
    14. Nutritional supplements
    15. Vitamin supplement patches
    16. Herbicide for agricultural use
    17. Pesticides for agricultural use
    18. Fungicides for agricultural use
    19. Medicines for veterinary purposes.
  • The mark was filed in class 42 with following description of goods:
    1. Chemical research
    2. Chemical analysis
    3. Chemistry consultation
    4. Cosmetic research
    5. Biological research
    6. Bacteriological research
    7. Conducting technical project studies
    8. Clinical trials
    9. Scientific laboratory services
    10. Scientific research
    11. Scientific research and development
    12. Research and development of new products for others
    13. Medical research
    14. Technological research in the field of medical instruments
    15. Product quality testing
    16. Scientific research for medical purposes in the area of cancerous diseases.